Form 4: NewAmsterdam Pharma Co Director Sells Shares
Insider Transaction (Form 4)
John W Smither, a Director of NewAmsterdam Pharma Co N.V., sold 1,600 shares of common stock on September 4, 2026 for $25.32 per share.
Summary
- Open-market sale: disposed of 1,600 Ordinary Shares at $25.32 ($40,512) on September 4, 2026; holds 8,760 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $40,512 of stock on the open market.
Insider Transactions
John W Smither — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-04 | Open-market sale | Ordinary Shares | 1,600 | $25 | $40.5K | 8,760 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-04 | Open-market sale (1,600 shares) |
Keywords
insider transaction, Form 4, NAMS, NewAmsterdam Pharma Co N.V., bearish, John W Smither
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.